GL1X · GenesisL1 explorer

Research workbench

Crystal structure of MURG:GLCNAC complex

Analyse Crystal structure of MURG:GLCNAC complex in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1NLM
Type
protein
Length
700 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.5
Source
Escherichia coli
Molecule
UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol…
EC
2.4.1.-
UniProt
P17443
Ligands
UD1
Pockets
5 · best druggability 0.80

Structure

x-ray diffraction · resolution 2.5 · 1 distinct chain · 48% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BUDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase (EC 2.4.1.-)protein35048% helix, 17% strandP17443

Ligands and binding sites

  • UD1 · Uridine-diphosphate-N-acetylglucosamine · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16370.800.8451GOL
24980.640.7663UD1, GOL
34240.600.7562UD1
4650.550.8717empty
5580.530.8718GOL

Interfaces

1 interface between chains.

  • A–B · 508 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 1NLM · Crystal structure of MURG:GLCNAC complex · the same entry in another collection · chain A against A, TM-score 1.00
  • P17443 · AlphaFold monomer V2.0 prediction for udp-N-acetylglucosamine… · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.